Welcome to our book review site go-pdf.online!

You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.

Sign up

Tissue-Resident Memory T Cells
  • Language: en
  • Pages: 183

Tissue-Resident Memory T Cells

Tissue-resident memory T (TRM) cells play a major role in control of viral infections. Their involvement in cancer diseases has been more recently demonstrated. This non-circulating T-lymphocyte subset lacks molecules enabling egress from the tissue and migration to lymph nodes, expresses specific markers of residency and displays specific transcription factors. The present special issue elucidates our current knowledge on CD8+ TRM cells and explores less frequently described resident subsets, such as CD4+ TRM and innate-like cells, as well as their specific metabolism and niches for their formation in infectious and cancer diseases.

Special Issue: Cancer Vaccines
  • Language: en
  • Pages: 93

Special Issue: Cancer Vaccines

  • Type: Book
  • -
  • Published: 2000
  • -
  • Publisher: Unknown

None

Cytokines and Cell Regulation
  • Language: en
  • Pages: 90

Cytokines and Cell Regulation

  • Type: Book
  • -
  • Published: 1997
  • -
  • Publisher: Unknown

None

Cancer Immunology and Immunotherapy
  • Language: en
  • Pages: 313

Cancer Immunology and Immunotherapy

The interplay between tumors and their immunologic microenvironment is complex, difficult to decipher, but its understanding is of seminal importance for the development of novel prognostic markers and therapeutic strategies. The present review discusses tumor-immune interactions in several human cancers that illustrate various aspects of this complexity and proposes an integrated scheme of the impact of local immune reactions on clinical outcome. Current active immunotherapy trials have shown durable tumor regressions in a fraction of patients. However, clinical efficacy of current vaccines is limited, possibly because tumors skew the immune system by means of myeloid-derived suppressor cells, inflammatory type 2 T cells and regulatory T cells (Tregs), all of which prevent the generation of effector cells. To improve the clinical efficacy of cancer vaccines in patients with metastatic disease, we need to design novel and improved strategies that can boost adaptive immunity to cancer, help overcome Tregs and allow the breakdown of the immunosuppressive tumor microenvironment.

Immunology of Infection
  • Language: en
  • Pages: 844

Immunology of Infection

Immunology of Infection, 2nd Edition, edited by two leading experts in the field, presents the most appropriate up-to-date experimental approaches in the detail required for modern microbiological research. Focusing on the methods most useful for the Microbiologist interested in analysing host-pathogen relationships, this volume will be essential reading for all researchers working in microbiology, immunology, virology, mycology and parasitology. This new edition of Immunology of Infection provides ready-to-use "recipes", and the latest emerging techniques as well as novel approaches to the tried and tested, established methods included in the successful first edition. Methods in Microbiolog...

Tumor Immunology and Immunotherapy
  • Language: en
  • Pages: 469

Tumor Immunology and Immunotherapy

Tumor immunology and immunotherapy provides a comprehensive account of cancer immunity and immunotherapy. Examining recent results, current areas of interest and the specific issues that are affecting the research and development of vaccines, this book provides insight into how these problems may be overcome as viewed by leaders in the field.

Towards New Promising Discoveries for Lung Cancer Patients: A Selection of Papers from the First Joint Meeting on Lung Cancer of the FHU OncoAge (Nice, France) and the MD Anderson Cancer Center (Houston, TX, USA)
  • Language: en
  • Pages: 230

Towards New Promising Discoveries for Lung Cancer Patients: A Selection of Papers from the First Joint Meeting on Lung Cancer of the FHU OncoAge (Nice, France) and the MD Anderson Cancer Center (Houston, TX, USA)

  • Type: Book
  • -
  • Published: 2019-09-17
  • -
  • Publisher: MDPI

This Special Issue of Cancers (Basel) is mainly dedicated to selecting papers from the talks given during the first Joint Meeting on Lung Cancer (JMLC) between the MD Anderson Cancer Center (Houston, Texas USA) and the Hospital University Federation (HUF) OncoAge (University Côte d’Azur, Nice, France) (Nice, September 2018). The central theme of JMLC is to discuss new advances and exchange ideas regarding lung cancer. Notably, the talks covered different topics on new therapeutic strategies (targeted therapy and immuno-oncology), molecular and cellular biology, biomarkers, and the epidemiology of lung cancer. Special attention was also given to lung cancer in elderly patients. The articles published in this Special Issue covered subjects such as the assessment of new biomarkers and new approaches for the early detection of lung cancer, epidemiological data, and emphasized a place for the newly characterized cellular pathways in lung cancer, which opens room for therapeutic perspectives for lung cancer patients.

Molecular Strategies Aimed to Boost NK Cell-based Immunotherapy of Cancer
  • Language: en
  • Pages: 146

Molecular Strategies Aimed to Boost NK Cell-based Immunotherapy of Cancer

In this Research Topic, we would like to honor the memory of Prof. Vito Pistoia and pay tribute to his scientific contributions to the field of Cancer Immunity and Immunotherapy. Topic Editor Daniel Olive is the co-founder and shareholder of company Imcheck Therapeutics. All other topic editors declare no competing interests with regards to the Research Topic subject.

Approaches to Advance Cancer Vaccines to Clinical Utility
  • Language: en
  • Pages: 196

Approaches to Advance Cancer Vaccines to Clinical Utility

Although cancer vaccines have yielded promising results both in vitro and in animal models, their translation into clinical application has not been very successful so far. Through the success of immune checkpoint inhibitors, the tumor immunotherapy field revived and led to important new insights. A better understanding of the functional capacity of different dendritic cell (DC) subsets and the immunogenicity of tumor antigens, more particularly of neoantigens, have important implications for the improvement of cancer vaccines. These insights can guide the development of novel strategies, to enhance the clinical utility of cancer vaccines. The aim of this Research Topic is therefore to provide a comprehensive overview of current issues regarding cancer vaccine development with an emphasis on novel approaches toward enhancing their efficacy.

Cancérologie fondamentale
  • Language: fr
  • Pages: 460

Cancérologie fondamentale

Cet ouvrage constitue le socle de notre connaissance de la cancérologie en ce début de XXIe siècle. De la molécule et de la cellule à l'homme et à la société, il explore toutes les composantes nécessaires à la compréhension de l'ontogenèse et du développement des cancers, ainsi que les bases de leur exploration, de leur traitement et de leur prévention. Chaque chapitre a été rédigé par un spécialiste du domaine, choisi en raison de ses qualités didactiques et de son activité innovante dans le domaine. Cet ouvrage s'adresse aux étudiants en médecine du premier et deuxième cycle, comme à ceux préparant un diplôme de spécialité ; il s'adresse également à tous les cancérologues désireux de comprendre les bases de leur pratique en cours d'évolution rapide. Sans prétendre à l'exhaustivité et au recensement de tous les mécanismes et de toutes les approches, il apporte en un volume unique une source d'information inégalée à ce jour dans l'édition francophone.